政府新闻
蔚来汽车CEO表示，新能源汽车销量翻一番是蔚来汽车今年的三大目标之一 - 2025年02月12日
Doubling electric vehicle sales is only one of Nio’s three targets for this year, according to the chairman and chief executive officer of the Chinese new energy vehicle startup.
上海小巫师：哈利·波特将在锦江公园施展魔法 - 2025年02月12日
China's first and the world's third Harry Potter Studio Tour will be launched in Shanghai, announced commercial conglomerate Jinjiang Group on Wednesday.
到2025年，上海将有新的文化和旅游景点 - 2025年02月11日
Shanghai will unveil new cultural and tourist landmarks in 2025. Let's check some of them out.
上海将发放服务业消费券 - 2025年02月11日
Shanghai will allocate 500 million yuan (US$69.73 million) from its municipal budget to issue vouchers for the service sector, local officials announced at a press briefing on Monday.
日本家具巨头宜得利计划在中国大规模扩张 - 2025年02月11日
Nitori Holdings will significantly boost its store number in China over the coming years as part of its global expansion plans, according to the vice president of Japan's biggest furniture and home accessories retailer.
上海阶梯医疗获得中国植入式脑机接口行业最大融资 - 2025年02月11日
Shanghai Stairmed Technology has secured CNY350 million (USD47.9 million) in its latest fundraiser, the largest single investment in the Chinese implantable brain-computer interface industry.
特斯拉耗资2亿美元的上海Megapack工厂投产 - 2025年02月11日
Tesla has launched production at its megafactory in Shanghai, its first plant to make Megapack energy storage batteries based outside of the United States, in which the US electric vehicle giant has invested over USD200 million.
国际著名歌手将在上海演出 - 2025年02月10日
Shanghai Culture Square will stage six concerts featuring internationally famous singers as part of the 2025 Musical Stars Live Concert Showcase.
上海征求关于新建住宅项目的舆论 - 2025年02月10日
Three new residential projects comprising 479 units of apartments were posted on the official website of Shanghai's real estate trade center to seek public opinions, according to a report by local news portal Shanghai Observer.
广州银诺的GLP-1注射剂被批准用于治疗成人2型糖尿病 - 2025年02月10日
A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based medical technology enterprise, was recently approved for market by China's National Medical Products Administration for the treatment of type 2 diabetes in adults.
